Legacy Wealth Asset Management, LLC Halozyme Therapeutics, Inc. Transaction History
Legacy Wealth Asset Management, LLC
- $331 Million
- Q2 2025
A detailed history of Legacy Wealth Asset Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Legacy Wealth Asset Management, LLC holds 4,955 shares of HALO stock, worth $341,795. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,955
Previous 3,945
25.6%
Holding current value
$341,795
Previous $251,000
2.39%
% of portfolio
0.08%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding HALO
# of Institutions
605Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.22 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$845 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$409 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$239 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$234 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.61B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...